
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 9 2024 | 12 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 18.78M | 27.91M | 31.6M | 37.5M | 47.73M | 69.55M | 90.38M | 99.41M |
営業利益 | -32.88M | -34.16M | -27.15M | -24.27M | -25.15M | -32.59M | -12.68M | -24.22M |
税引前収入 | -35.69M | -36.29M | -29.93M | -73.72M | -23.34M | -35.43M | -13.89M | -24.37M |
純利益 | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -14.24M | -23.79M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -33.07M | -34.75M | -27.96M | -24.55M | -72.9M | -35.41M | -13.77M | -25.19M |
EBITDA | -31.79M | -32.96M | -25.81M | -22.94M | -22.49M | -27.09M | -6.63M | -18.17M |
年末 2024年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 19.14M | 77.06M | 186.37M | 336.89M |
営業利益 | -17.41M | -54.74M | -104.3M | -173.41M | -131.22M | -109.15M | -87.61M |
税引前収入 | -17.35M | -52.53M | -103.26M | -83.95M | -142.07M | -162.42M | -86.91M |
純利益 | -17.35M | -52.55M | -103.27M | -83.99M | -135.67M | -163.42M | -87.94M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.406 | -2.325 | -3.468 | -2.746 | -3.671 | -3.506 | -1.832 |
EBIT | -17.41M | -54.76M | -104.49M | -66M | -130.86M | -161.05M | -87.59M |
EBITDA | -17.41M | -54.6M | -103.99M | -172.82M | -127.98M | -98.33M | -63.98M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約